|
108
|
327
|
5otyA |
The crystal structure of ck2alpha in complex with cam4712 |
|
112
|
327
|
5ouuA |
The crystal structure of ck2alpha in complex with compound 22 |
|
105
|
334
|
5owhA |
High salt structure of human protein kinase ck2alpha in complex with 3-aminopropyl-4,5,6,7-tetrabromobenzimidazol |
|
109
|
324
|
5oquA |
The crystal structure of ck2alpha in complex with compound 5 |
|
105
|
324
|
5orkA |
The crystal structure of ck2alpha in complex with compound 6 |
|
115
|
327
|
5otsA |
The crystal structure of ck2alpha in complex with an analogue of compound 22 |
|
109
|
327
|
5otpA |
The crystal structure of ck2alpha in complex with an analogue of compound 22 |
|
108
|
326
|
5oumA |
The crystal structure of ck2alpha in complex with compound 21 |
|
116
|
326
|
5ot5A |
The crystal structure of ck2alpha in complex with compound 24 |
|
111
|
328
|
5oslA |
The crystal structure of ck2alpha in complex with compound 7 |
|
113
|
327
|
5otiA |
The crystal structure of ck2alpha in complex with compound 27 |
|
111
|
327
|
5otoA |
The crystal structure of ck2alpha in complex with compound 30 |
|
114
|
327
|
5otdA |
The crystal structure of ck2alpha in complex with compound 25 |
|
115
|
331
|
5nqcA |
Ck2alpha in complex with nmr154 |
|
110
|
329
|
5n9kA |
Crystal structure of human protein kinase ck2 catalytic subunit in complex with the atp-competitive, tight-binding dibenzofuran inhibitor tf107 (5) |
|
113
|
331
|
5h8bA |
Crystal structure of ck2 with compound 2 |
|
115
|
331
|
5h8eA |
Crystal structure of ck2 with compound 7h |
|
105
|
326
|
5h8gA |
Crystal structure of ck2 with compound 7b |
|
112
|
329
|
5b0xA |
Crystal structure of the ck2a/benzoic acid derivative complex |
|
113
|
326
|
5cvgA |
Crystal structure of ck2alpha with a novel closed conformation of the ad loop |
|
111
|
327
|
5cvfA |
Crystal structure of ck2alpha with compound 5 bound |
|
112
|
327
|
5cu6A |
Crystal structure of ck2alpha |
|
116
|
325
|
5cu3A |
Crystal structure of ck2alpha with compound 10 bound |
|
111
|
324
|
5ctpA |
Crystal structure of ck2alpha with n-(3-(3-chloro-4-(phenyl)benzylamino)propyl)acetamide bound |
|
112
|
327
|
5cvhA |
Crystal structure of ck2alpha |
|
113
|
328
|
5cx9A |
Crystal structure of ck2alpha with (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4-oxobutanoate bound |
|
112
|
327
|
5cs6A |
Crystal structure of ck2alpha with compound 3 bound |
|
110
|
327
|
5csvA |
Crystal structure of ck2alpha with compound 6 bound |
|
101
|
328
|
5cquA |
Monoclinic complex structure of protein kinase ck2 catalytic subunit with a benzotriazole-based inhibitor generated by click-chemistry |
|
107
|
331
|
5cqwA |
Tetragonal complex structure of protein kinase ck2 catalytic subunit with a benzotriazole-based inhibitor generated by click-chemistry |
|
112
|
327
|
5cu4A |
Crystal structure of ck2alpha with compound 10 bound |
|
111
|
326
|
5ct0A |
Crystal structure of ck2alpha with 3-(3-chloro-4-(phenyl)benzylamino)propan-1-ol bound |
|
113
|
328
|
5cu2A |
Crystal structure of ck2alpha with 2-hydroxy-5-methylbenzoic acid and (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4-oxobutanoat bound |
|
110
|
324
|
5cshA |
Crystal structure of ck2alpha with compound 4 bound |
|
111
|
327
|
5clpA |
Crystal structure of ck2alpha with 3,4-dichlorophenethylamine bound |
|
107
|
333
|
4ubaA |
Low-salt structure of protein kinase ck2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (flc26) |
|
110
|
334
|
4ub7A |
High-salt structure of protein kinase ck2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (flc26) showing an extreme distortion of the atp-binding loop combined with a pi-halogen bond |
|
106
|
329
|
4rllA |
Crystal structure of human ck2alpha in complex with the atp-competitive inhibitor 4-[(e)-(fluoren-9-ylidenehydrazinylidene)-methyl] benzoate |
|
114
|
327
|
4rlkA |
Crystal structure of z. mays ck2alpha in complex with the atp-competitive inhibitor 4-[(e)-(fluoren-9-ylidenehydrazinylidene)-methyl] benzoate |
|
46
|
201
|
4nh1C |
Crystal structure of a heterotetrameric ck2 holoenzyme complex carrying the andante-mutation in ck2beta and consistent with proposed models of autoinhibition and trans-autophosphorylation |
|
96
|
330
|
4nh1A |
Crystal structure of a heterotetrameric ck2 holoenzyme complex carrying the andante-mutation in ck2beta and consistent with proposed models of autoinhibition and trans-autophosphorylation |
|
128
|
371
|
4mwhA |
Crystal structure of scck2 alpha in complex with atp |
|
101
|
329
|
4kwpA |
Crystal structure of human ck2-alpha in complex with a benzimidazole inhibitor (k164) at 1.25 a resolution |
|
137
|
370
|
4lfiA |
Crystal structure of scck2 alpha in complex with gmppnp |
|
1
|
13
|
4ib5D |
Structure of human protein kinase ck2 catalytic subunit in complex with a ck2beta-competitive cyclic peptide |
|
110
|
331
|
4ib5A |
Structure of human protein kinase ck2 catalytic subunit in complex with a ck2beta-competitive cyclic peptide |
|
130
|
369
|
4jqeA |
Crystal structure of scck2 alpha in complex with amppn |
|
131
|
372
|
4jr7A |
Crystal structure of scck2 alpha in complex with gmppnp |
|
100
|
329
|
4gubA |
Casein kinase ii bound to inhibitor |
|
118
|
327
|
4grbA |
Casein kinase 2 (ck2) bound to inhibitor |
